George Abercrombie
Director/Board Member presso BIOCRYST PHARMACEUTICALS, INC.
Patrimonio netto: 150 424 $ in data 31/03/2024
Profilo
George B.
Abercrombie is currently an Independent Director at BioCryst Pharmaceuticals, Inc. and a Director at Physicians Interactive Holdings LLC.
He is also a Director at the North Carolina Glaxosmithkline Foundation, Hessian Pharmaceuticals, Inc., and the North Carolina Board of Science & Technology.
Additionally, he serves as an Adjunct Professor at The Fuqua School of Business.
In his former positions, Abercrombie served as the President & CEO-Pharmaceuticals Operations at Roche Holding AG.
He was also the President & Chief Executive Officer at Hoffmann-La Roche, Inc. from 2001 to 2009.
Abercrombie held the position of President & Chief Executive Officer at Roche Laboratories, Inc. and Vice Chairman at Project HOPE-The-People-To-People Health Foundation, Inc. He has also served as a Director at Vical, Inc., Inspire Pharmaceuticals, Inc., DemeRx, Inc., Brickell Subsidiary, Inc., OCERA Therapeutics LLC, Alaunos Therapeutics, Inc., Pharmaceutical Research & Manufacturers of America, Aptus Health, Inc., Tranzyme Pharma, Inc. (Canada), Johns Hopkins Bloomberg School of Public Health, Fresh Tracks Therapeutics, Inc., and Merck & Co., Inc. Abercrombie was the Chief Commercial Officer & Senior Vice President at Innoviva, Inc. from 2014 to 2018 and the Senior Vice President-US Commercial Operations at Glaxo Wellcome, Inc. from 1993 to 2001.
Abercrombie holds an MBA from Harvard University and an undergraduate degree from The University of North Carolina at Chapel Hill.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
| 13/06/2023 | 29 611 ( 0.01% ) | 150 424 $ | 31/03/2024 |
Posizioni attive di George Abercrombie
| Società | Posizione | Inizio |
|---|---|---|
| BIOCRYST PHARMACEUTICALS, INC. | Director/Board Member | 24/05/2017 |
| North Carolina Board of Science & Technology | Corporate Officer/Principal | - |
| Hessian Pharmaceuticals, Inc. | Director/Board Member | - |
| North Carolina Glaxosmithkline Foundation | Director/Board Member | - |
Physicians Interactive Holdings LLC
 Physicians Interactive Holdings LLC Commercial Printing/FormsCommercial Services Physicians Interactive Holdings LLC operates as a holding company with interest in providing online and mobile clinical resources and solutions. Its services include digital marketing, mobile media platform, sampling, data analytics, and campaign development. The company was founded by Donato J. Tramuto in 2008 and is headquartered in Reading, MA. | Director/Board Member | 24/09/2013 |
| The Fuqua School of Business | Corporate Officer/Principal | - |
Precedenti posizioni note di George Abercrombie
| Società | Posizione | Fine |
|---|---|---|
| FRESH TRACKS THERAPEUTICS, INC. | Director/Board Member | 27/05/2020 |
| INNOVIVA, INC. | Corporate Officer/Principal | 26/09/2018 |
| OCERA THERAPEUTICS INC | Director/Board Member | 11/11/2013 |
| ░░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
Formazione di George Abercrombie
| Harvard University | Masters Business Admin |
| The University of North Carolina at Chapel Hill | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 6 |
|---|---|
| BIOCRYST PHARMACEUTICALS, INC. | Health Technology |
| MERCK & CO., INC. | Health Technology |
| ROCHE HOLDING AG | Health Technology |
| INNOVIVA, INC. | Health Technology |
| ALAUNOS THERAPEUTICS, INC. | Health Technology |
| FRESH TRACKS THERAPEUTICS, INC. | Health Technology |
| Aziende private | 16 |
|---|---|
Vical, Inc.
 Vical, Inc. Pharmaceuticals: MajorHealth Technology Vical, Inc. engages in the research and development of biopharmaceutical products based on patented DNA delivery technologies for the prevention and treatment of serious and life-threatening diseases. It focuses on the antifungal VL-2397, which treats patients with invasive aspergillosis. Its products include Vaxfectin, a cationic lipid formulation optimized to increase the immune response to vaccines. The company was founded by Howard E. Greene, Jr. Timothy J. Wollaeger, Karl Y. Hostetler, and Douglas D. Richman in April 1987 and is headquartered in San Diego, CA. | Health Technology |
Inspire Pharmaceuticals, Inc.
 Inspire Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Inspire Pharmaceuticals, Inc. operated as a biopharmaceutical company. It discovered and developed pharmaceutical products to treat diseases that results from deficiencies in the body's natural mechanisms of mucosal hydration. The company was founded by Kendall Harden, Richard C. Boucher, Andre L. Lamotte, H. Jefferson Leighton and Terrance G. McGuire and was headquartered in Whitehouse Station, NJ. | Health Technology |
DemeRx, Inc.
 DemeRx, Inc. BiotechnologyHealth Technology DemeRx, Inc. provides biotechnology services. It focuses on drug addiction among patients coping with chronic pain. The company was founded by Deborah C. Mash on March 1, 2010 and is headquartered in Miami, FL. | Health Technology |
Brickell Subsidiary, Inc.
 Brickell Subsidiary, Inc. Pharmaceuticals: MajorHealth Technology Brickell Subsidiary, Inc. operates as a clinical-stage pharmaceutical company. It focuses on the development of differentiated, innovative drug therapies for the treatment of skin diseases. The firm specializes in Hyperhidrosis, Cutaneous T-Cell Lymphoma and Psoriasis areas. The company was founded by Reginald L. Hardy and Andrew D. Sklawer in November 2009 and is headquartered in Boulder, CO. | Health Technology |
Hoffmann-La Roche, Inc.
 Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Hoffmann-La Roche, Inc. manufactures pharmaceutical drugs. Its products include influenza fighter Tamiflu, controversial acne medication Accutane, HIV inhibitor Fuzeon, obesity drug Xenical, and hepatitis C therapy Pegasys. The company was founded in 1896 Roche and is headquartered in Nutley, NJ. | Health Technology |
Ocera Therapeutics, Inc.
 Ocera Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Ocera Therapeutics, Inc. manufactures pharmaceuticals products. The company was founded in 2004 and is headquartered in Hazelwood, MO. | Health Technology |
Pharmaceutical Research & Manufacturers of America
 Pharmaceutical Research & Manufacturers of America Pharmaceuticals: MajorHealth Technology Pharmaceutical Research & Manufacturers of America provides pharmaceutical research and biotechnology services. It represents the country’s biopharmaceutical research companies, which are devoted to discovering and developing medicines that enable patients to live longer, healthier, and more productive lives. The company was founded in 1958 and is headquartered Washington, DC. | Health Technology |
Project HOPE-The-People-To-People HealthFoundation, Inc.
 Project HOPE-The-People-To-People HealthFoundation, Inc. Medical/Nursing ServicesHealth Services Project HOPE-The-People-To-People HealthFoundation, Inc. provides solutions to health problems. The firm trains health professionals and build medical facilities in areas devastated by conflict, natural disasters, and poverty. It addresses infectious diseases, health professional education, women's and children's health, humanitarian assistance, and the need for health systems and facilities. The company was founded by William B. Walsh in 1958 and is headquartered in Millwood, VA. | Health Services |
Roche Laboratories, Inc.
 Roche Laboratories, Inc. Medical DistributorsDistribution Services Part of Roche Holding AG, Roche Laboratories, Inc. markets and sells pharmaceutical medications. The private company is based in Nutley, NJ. | Distribution Services |
| Glaxo Wellcome, Inc. | Health Technology |
Aptus Health, Inc.
 Aptus Health, Inc. Miscellaneous Commercial ServicesCommercial Services Aptus Health, Inc. operates a marketing platform for physicians and health care professionals. Its services include Geo-targeting mobile advertising; clinical alerts and eNewsletters; insight and attitudinal surveys; KOL-led presentations; eDetails; Peer-to-Peer collaboration; eSampling; Electronic Health Record integration; patient feedback; segmentation and tartgeting; behavioral insights; and intelligence and reporting. The company was founded by Donato J. Tramuto in 2008 and is headquartered in Reading, MA. | Commercial Services |
| Tranzyme Pharma, Inc. (Canada) | |
| North Carolina Board of Science & Technology | |
Physicians Interactive Holdings LLC
Physicians Interactive Holdings LLC Commercial Printing/FormsCommercial Services Physicians Interactive Holdings LLC operates as a holding company with interest in providing online and mobile clinical resources and solutions. Its services include digital marketing, mobile media platform, sampling, data analytics, and campaign development. The company was founded by Donato J. Tramuto in 2008 and is headquartered in Reading, MA. | Commercial Services |
| North Carolina Glaxosmithkline Foundation | |
| Hessian Pharmaceuticals, Inc. |
- Borsa valori
- Insiders
- George Abercrombie
